Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis

被引:20
作者
Le Thi Thanh Thuy [1 ]
Hai, Hoang [1 ]
Kawada, Norifumi [1 ]
机构
[1] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka, Japan
基金
日本学术振兴会;
关键词
Cytoglobin; Hepatic stellate cells; Fibrosis; Free radical scavengers; Antioxidants; FAT-STORING CELLS; NITRIC-OXIDE; LIPID-PEROXIDATION; LIVER FIBROSIS; NONALCOHOLIC STEATOHEPATITIS; OVEREXPRESSION PROTECTS; SUPEROXIDE-DISMUTASE; NITROSATIVE STRESS; COLLAGEN-SYNTHESIS; CRYSTAL-STRUCTURE;
D O I
10.3350/cmh.2020.0037
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cytoglobin (Cygb), a stellate cell-specific globin, has recently drawn attention due to its association with liver fibrosis. In the livers of both humans and rodents, Cygb is expressed only in stellate cells and can be utilized as a marker to distinguish stellate cells from hepatic fibroblast-derived myofibroblasts. Loss of Cygb accelerates liver fibrosis and cancer development in mouse models of chronic liver injury including diethylnitrosamine-induced hepatocellular carcinoma, bile duct ligation-induced cholestasis, thioacetamide-induced hepatic fibrosis, and choline-deficient L-amino acid-defined diet-induced non-akoholic steatohepatitis. This review focuses on the history of research into the role of reactive oxygen species and nitrogen species in liver fibrosis and discusses the current perception of Cygb as a novel radical scavenger with an emphasis on its role in hepatic stellate cell activation and fibrosis.
引用
收藏
页码:280 / 293
页数:14
相关论文
共 50 条
[31]   Ferroptosis contribute to hepatic stellate cell activation and liver fibrogenesis [J].
Cho, Sam Seok ;
Yang, Ji Hye ;
Lee, Ji Hyun ;
Baek, Jin Sol ;
Ku, Sae Kwang ;
Cho, Il Je ;
Kim, Kyu Min ;
Ki, Sung Hwan .
FREE RADICAL BIOLOGY AND MEDICINE, 2022, 193 :620-637
[32]   Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis [J].
Garbuzenko, Dmitry Victorovich .
WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (12) :3662-3676
[33]   Lyn kinase enhanced hepatic fibrosis by modulating the activation of hepatic stellate cells [J].
Li, Yin ;
Xiong, Lin ;
Gong, Jianping .
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 9 (06) :2865-2877
[34]   Co-administration of everolimus and N-acetylcysteine attenuates hepatic stellate cell activation and hepatic fibrosis [J].
Choi, Yoon Young ;
Seok, Jin-, I ;
Hwang, Jong-Ik ;
Kim, Dong-Sik .
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (06) :2627-2639
[35]   Altered aquaporin expression and role in apoptosis during hepatic stellate cell activation [J].
Lakner, Ashley M. ;
Walling, Tracy L. ;
McKillop, Iain H. ;
Schrum, Laura W. .
LIVER INTERNATIONAL, 2011, 31 (01) :42-51
[36]   A Novel Flow Cytometry Tool for Fibrosis Scoring Through Hepatic Stellate Cell Differentiation [J].
Amer, Johnny ;
Salhab, Ahmad ;
Doron, Sarit ;
Morali, Gilles ;
Safadi, Rifaat .
CYTOMETRY PART A, 2018, 93A (04) :427-435
[37]   Role of Hepatocyte Senescence in the Activation of Hepatic Stellate Cells and Liver Fibrosis Progression [J].
Wijayasiri, Pramudi ;
Astbury, Stuart ;
Kaye, Philip ;
Oakley, Fiona ;
Alexander, Graeme J. ;
Kendall, Timothy J. ;
Aravinthan, Aloysious D. .
CELLS, 2022, 11 (14)
[38]   Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation [J].
Guo, Ren ;
Jia, Xiaohui ;
Ding, Zhenbin ;
Wang, Gang ;
Jiang, Mengmeng ;
Li, Bing ;
Chen, Shanshan ;
Xia, Bingqing ;
Zhang, Qing ;
Liu, Jian ;
Zheng, Ruting ;
Gao, Zhaobing ;
Xie, Xin .
THERANOSTICS, 2022, 12 (11) :5220-5236
[39]   Inhibition of hepatic stellate cell activation and liver fibrosis by fat-specific protein 27 [J].
Fuxiang Yu ;
Longfeng Su ;
Shiqiang Ji ;
Shengchu Zhang ;
Panpan Yu ;
Yihu Zheng ;
Qiyu Zhang .
Molecular and Cellular Biochemistry, 2012, 369 :35-43
[40]   Salvianolic acid B inhibits hepatic stellate cell activation and liver fibrosis by targeting PDGFRβ [J].
Liu, Fangbin ;
Li, Shengnan ;
Chen, Panpan ;
Gu, Yanqiu ;
Wang, Shaozhan ;
Wang, Lei ;
Chen, Chun ;
Wang, Rong ;
Yuan, Yongfang .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 122